| Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years S Frangou, A Modabbernia, SCR Williams, E Papachristou, GE Doucet, ... Human brain mapping 43 (1), 431-451, 2022 | 236* | 2022 |
| Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study O Caseiro, R Pérez-Iglesias, I Mata, O Martínez-Garcia, JM Pelayo-Terán, ... Journal of psychiatric research 46 (8), 1099-1105, 2012 | 165 | 2012 |
| Virtual histology of cortical thickness and shared neurobiology in 6 psychiatric disorders Y Patel, N Parker, J Shin, D Howard, L French, SI Thomopoulos, E Pozzi, ... JAMA psychiatry 78 (1), 47-63, 2021 | 123 | 2021 |
| Using machine learning and structural neuroimaging to detect first episode psychosis: reconsidering the evidence S Vieira, Q Gong, WHL Pinaya, C Scarpazza, S Tognin, B Crespo-Facorro, ... Schizophrenia bulletin 46 (1), 17-26, 2020 | 94 | 2020 |
| Genetic variants associated with longitudinal changes in brain structure across the lifespan RM Brouwer, M Klein, KL Grasby, HG Schnack, N Jahanshad, J Teeuw, ... Nature neuroscience 25 (4), 421-432, 2022 | 93 | 2022 |
| Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study J Mayoral-van Son, VOG de la Foz, O Martinez-Garcia, T Moreno, ... The Journal of clinical psychiatry 77 (4), 2893, 2016 | 72 | 2016 |
| Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies—PSYSCAN: translating neuroimaging findings from research into clinical practice S Tognin, HH van Hell, K Merritt, I Winter-van Rossum, MG Bossong, ... Schizophrenia bulletin 46 (2), 432-441, 2020 | 69 | 2020 |
| Neuroharmony: A new tool for harmonizing volumetric MRI data from unseen scanners R Garcia-Dias, C Scarpazza, L Baecker, S Vieira, WHL Pinaya, A Corvin, ... Neuroimage 220, 117127, 2020 | 59 | 2020 |
| Tobacco smoking and its association with cognition in first episode psychosis patients LM Hickling, R Perez-Iglesias, VOG de la Foz, V Balanzá-Martínez, ... Schizophrenia research 192, 269-273, 2018 | 53 | 2018 |
| Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized … MJ Morlán-Coarasa, MT Arias-Loste, V Ortiz-García de la Foz, ... Psychopharmacology 233, 3947-3952, 2016 | 49 | 2016 |
| Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study B Crespo-Facorro, VOG de la Foz, R Ayesa-Arriola, R Pérez-Iglesias, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 44, 162-167, 2013 | 46 | 2013 |
| Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study M Juncal-Ruiz, L Riesco-Dávila, VOG de la Foz, O Martínez-Garcia, ... Schizophrenia research 202, 226-233, 2018 | 43 | 2018 |
| Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP) JM Pelayo-Terán, VG Gajardo Galan, V de la Ortiz-García de la Foz, ... European archives of psychiatry and clinical neuroscience 267, 315-323, 2017 | 42 | 2017 |
| Brain structural and clinical changes after first episode psychosis: focus on cannabinoid receptor 1 polymorphisms P Suárez-Pinilla, R Roiz-Santiañez, VOG de la Foz, PC Guest, ... Psychiatry Research: Neuroimaging 233 (2), 112-119, 2015 | 41 | 2015 |
| Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis R Pérez-Iglesias, VOG de la Foz, OM García, JA Amado, ... Schizophrenia research 159 (1), 90-94, 2014 | 41 | 2014 |
| Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment M Juncal-Ruiz, M Ramirez-Bonilla, J Gomez-Arnau, ... Psychopharmacology 234, 2563-2570, 2017 | 40 | 2017 |
| Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine R Roiz-Santiáñez, D Tordesillas-Gutiérrez, VOG de la Foz, ... Schizophrenia research 141 (1), 22-28, 2012 | 40 | 2012 |
| Understanding sex differences in long-term outcomes after a first episode of psychosis R Ayesa-Arriola, VOG de la Foz, E Setién-Suero, ML Ramírez-Bonilla, ... Npj Schizophrenia 6 (1), 33, 2020 | 39 | 2020 |
| Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis B Crespo-Facorro, R Pérez-Iglesias, I Mata, O Martínez-Garcia, V Ortiz, ... Psychopharmacology 219, 225-233, 2012 | 39 | 2012 |
| Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients R Roiz-Santiáñez, R Ayesa-Arriola, D Tordesillas-Gutiérrez, ... Psychological Medicine 44 (8), 1591-1604, 2014 | 38 | 2014 |
